Changes

no edit summary
Line 559: Line 559:  
|-
 
|-
 
|RESOLVE 4th edition AML-Related NON-WHO entities content
 
|RESOLVE 4th edition AML-Related NON-WHO entities content
|
+
|Acute Myeloid Leukemia (AML) with Mutated FLT3 + Acute Myeloid Leukemia (AML) with NUP214-ABL1 + Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6
|
+
|ISSUE - FIX
 
|
 
|
 
|
 
|
Line 672: Line 672:  
|Myeloid/lymphoid neoplasm with JAK2 rearrangement
 
|Myeloid/lymphoid neoplasm with JAK2 rearrangement
 
|Disease
 
|Disease
|Resolve Non-WHO entities
+
|ISSUE- FOX
 +
 
 +
 
 +
Resolve Non-WHO entities
 
|
 
|
 
|
 
|
Line 1,370: Line 1,373:  
|
 
|
 
|HD
 
|HD
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|RESOLVE 4th edition ALL-Related NON-WHO entities content
 +
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 + B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 + B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements + B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions + B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) + B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
 +
|ISSUE - FIX
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|